Masseter / V-line Botox
Masseter BoNT-A for lower-face slimming and clenching control
이 치료에 대해
Masseter Botox injects BoNT-A into hypertrophic masseters to address square jaw, clenching, bruxism and lower-face width. It is common in Korean and East Asian V-line protocols and is also used in the US and Europe for functional and aesthetic goals.
작용 기전
BoNT-A reduces masseter activity and thickness over weeks. Bony jaw width responds poorly, and patients with laxity may notice more lower-face looseness.
적응증
기대 효과
Lower-face volume reduction is assessed at 4-12 weeks. Repeated treatment can further reduce muscle thickness but may affect chewing strength or reveal laxity.
임상 근거
위험 및 부작용
Reduced chewing strength, smile asymmetry, hollowing, laxity, bruising and headache may occur. Accurate placement is needed to avoid diffusion to nearby structures.